Intellia Therapeutics, Inc. (NTLA) has 4 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $507K. Most recent filing: Aug. 24, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 24, 2026 filed Aug. 20, 2026 | LEONARD JOHN M President and CEO | −$286,819 | 22,675 | −2% | Yes | |
|
|
||||||
| July 24, 2026 filed July 22, 2026 | Dulac Edward J III EVP, Chief Financial Officer | −$91,249 | 8,111 | −5% | No | |
|
|
||||||
| July 6, 2026 filed July 1, 2026 | Dube Michael P VP, Chief Accounting Officer | −$44,316 | 2,641 | −4% | No | |
|
|
||||||
| July 6, 2026 filed July 2, 2026 | Dulac Edward J III EVP, Chief Financial Officer | −$84,186 | 4,677 | −3% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free